Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-25

Clinical Trial Update: The VIS Opti-K Low Vision Aid Device Provides Vision Improvement. [NA]

View source ↗

Summary

Update reports that the VIS Opti-K Low Vision Aid provides vision improvement for hyperopia and presbyopia. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIS Opti-K Low Vision Aid

Snippet

Sponsor: VIS, Inc. | Conditions: Hyperopia, Presbyopia | NA | Status: NOT_YET_RECRUITING